CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of CorMedix Stockholders and Encourages Investors to Contact the Firm

Group 1 - CorMedix Inc. is under investigation by Bragar Eagel & Squire, P.C. for potential violations of federal securities laws and unlawful business practices [1] - On March 25, 2025, CorMedix reported its fourth quarter and full year 2024 financial results, indicating expectations of net price erosion starting in Q2 2025, which led to a decline in the company's stock price [2] - The law firm is reaching out to long-term stockholders of CorMedix who may have suffered losses and is encouraging them to participate in the investigation [3] Group 2 - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents investors in various complex litigations across state and federal courts [4]